companies / amidebio-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-05 json
| total_raised | 1,929,4081.9M | ○ |
|---|---|---|
| founded | 2009 | |
| hq | BOULDER, Colorado, USA | |
| industry | unknown | |
| stage | null |
Develops novel peptide drug candidates for metabolic disease and offers high-purity custom peptide synthesis to pharma and academic clients. Sells to biotech and pharma teams running peptide-therapeutic discovery programs. Combines in-silico peptide design with proprietary synthesis routes that improve purity and unit cost.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-09-01 | grant | 1,900,0001.9M | null | ○ |
WordPress, Apache HTTP Server 2.4.52, Yoast SEO 27.6, Ubuntu, Slider Revolution 6.7.41, Jetpack, jQuery Migrate 3.4.1, Contact Form 7 6.1.6, Cornerstone 7.8.8, WooCommerce, Boost.ai, PHP
| fact | status | src |
|---|---|---|
| Grant, $1.9M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |